INSM Q1 2025 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$93M+22.9% YoY

Gross Profit

$72M77.1% margin

Operating Income

-$248M-267.3% margin

Net Income

-$257M-276.4% margin

EPS (Diluted)

$-1.42

QoQ Revenue Growth

-11.1%

Cash Flow

Operating Cash Flow

-$262M

Free Cash Flow

-$272M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.7B

Stockholders' Equity

$99M

Cash & Equivalents

$403M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$76M	+22.9%
Gross Profit	$72M	$58M	+23.3%
Operating Income	-$248M	-$146M	-70.5%
Net Income	-$257M	-$157M	-63.3%

Revenue Segments

Reportable Segment

$93M100%

Geographic Segments

UNITED STATES

$64M69%

JAPAN

$22M24%

Europe And The Rest Of The World

$6M7%